FDA
approval
· 2024-03-27
FDA Approved: ESLICARBAZEPINE ACETATE — Original Application (Lupin Pharmaceuticals, Inc.)
Summary
FDA approves Lupin's generic eslicarbazepine acetate (original application) for use in treating partial-onset seizures in adults.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for ESLICARBAZEPINE ACETATE (ESLICARBAZEPINE ACETATE)